Ikris is trusted for ensuring a 100% regulatory-compliant supply of hard-to-access medicines not yet available in India or emerging markets.
ACCESS WITHOUT BORDERS. CARE WITHOUT DELAY
Your trusted partner in early access to global oncology medicines.
We’re India’s biggest company in the field of the Named Patient Import Program. We facilitate access to life-saving medicines that are either unavailable or unapproved in the Indian market through 100% ethical and compliant channels.
Join us at ESMO to explore how we help oncologists close treatment gaps with fast, compliant, and compassionate support.
Be part of a global conversation on early access, regulatory pathways, and innovative supply solutions with Ikris Pharma Network.
Ikris Pharma Network specializes in providing 100% compliant and ethical access
to unapproved or unavailable medicines in India through the Named Patient Import Program.
With strong global partnerships and experience in facilitating Patient Assistance Programs (PAP),
we help bridge treatment gaps and support timely access to breakthrough therapies—especially
in oncology and rare diseases.
Ikris is trusted for ensuring a 100% regulatory-compliant supply of hard-to-access medicines not yet available in India or emerging markets.
We partner with global innovators to bring transformative therapies to patients in need—especially for oncology and rare diseases.
Every shipment is sourced directly from licensed manufacturers or their authorized distributors.
Fully compliant with CDSCO’s regulations, DGFT import permits, and WHO-GDP standards.
© Copyright 2025 -Ikris Pharma Network. All Right Reserved
1800-889-1064
Mail Us Now